Schedule

The Critical Care Pharmacy Preparatory Review Course will be held Saturday and Sunday, April 25-26, 2020.

Click below for the full meeting schedule.

ACCP Spring Forum Preparatory
Review and Recertification Courses
April 25-26, 2020

Critical Care Pharmacy Preparatory Review and Recertification Course -- Management of Pain, Agitation, Delirium, and Neuromuscular Blockade and Adult Intensive Care Unit Patients, Supportive and Preventative Medicine, Fluids, Electrolytes, Acid Base Disorders, and Nutrition Support

Saturday, April 27, 2019 from 8:00 AM to 11:30 AM CDT at Academic and Research Building: First Floor, Room 111

Available for 3.25 hours of CPE credit
Activity Number: 0217-0000-19-070-L01-P

Management of Pain, Agitation, Delirium, and Neuromuscular Blockade in Adult Intensive Care Unit Patients
8:00 AM to 9:00 AM
Academic and Research Building: First Floor, Room 111

Speakers
Speaker: Joanna L. Stollings, Pharm.D., FCCM, FCCP, BCPS, BCCCP
Medical Intensive Care Unit Clinical Pharmacy Specialist Vanderbilt University Medical Center Nashville, Tennessee
View Biography
Joanna L. Stollings, Pharm.D., FCCM, FCCP, BCPS, BCCCP
Stollings

Learning Objectives
1. Develop a management strategy for the prevention and treatment of pain, agitation, delirium, immobility and sleep (PAD) in an intensive care unit (ICU) patient with various comorbidities.
2. Discuss relevant pharmacokinetic and pharmacodynamic considerations of PADIS medications as they pertain to disturbances in critical care physiology.
3. Identify relevant adverse effects, drug interaction, and drug withdrawal syndromes in the management of PADIS.
4. Evaluate patients in the ICU for PADIS using a validated screening tool.
5. Construct a plan for the management of delirium.
6. Identify the long-term effects of critical illness in adult ICU patients
7. Create a management strategy for PADIS-related medications that are continued beyond ICU discharge.
8. Describe a treatment and monitoring plan for critically ill patients receiving neuromuscular blockade.
Supportive and Preventative Medicine
9:00 AM to 9:45 AM
Academic and Research Building: First Floor, Room 111

Speakers
Speaker: Amy L. Dzierba, Pharm.D., FCCM, BCPS, BCCCP
Clinical Specialist, Critical Care Program Director, Critical Care Residency Department of Pharmacy, New York Presbyterian Hospital, New York, New York
View Biography
Amy L. Dzierba, Pharm.D., FCCM, BCPS, BCCCP
Dzierba

Learning Objectives
1. Identify the importance of the key components of intensive care medicine that can be applied to all critically ill patients.
2. Recommend therapeutic options to prevent stress-related mucosal disease.
3. Recommend therapeutic options to prevent venous thromboembolism in a critically ill patient.
4. Discuss therapeutic options for patients with heparin-induced thrombocytopenia.
5. Discuss medications that can be used to provide comfort to a critically ill patient at the end of life.
Break
9:45 AM to 10:00 AM
Fluids, Electrolytes, Acid Base Disorders, and Nutrition Support
10:00 AM to 11:30 AM
Academic and Research Building: First Floor, Room 111

Speakers
Speaker: Roland N. Dickerson, Pharm.D., FCCP, BCNSP
Professor of Clinical Pharmacy, University of Tennessee College of Pharmacy, Memphis, Tennessee
View Biography
Roland N. Dickerson, Pharm.D., FCCP, BCNSP
Dickerson

Learning Objectives
1. Describe normal fluid requirements, and identify common patient conditions that alter fluid needs and homeostasis.
2. Assess hyponatremia and hypernatremia in a critically ill patient, and develop an appropriate treatment plan.
3. Discuss the causes and treatment of common intra¬cellular electrolyte disorders.
4. Differentiate between the causative factors for metabolic acidosis and alkalosis, and construct a therapeutic treatment algorithm.
5. Specify the appropriate route (parenteral or enteral) of nutrition administration, amount of nutrients, and micronutrients to be provided to a given critically ill patient.
6. Identify appropriate markers for assessing the tol¬erance, safety, and efficacy of enteral or parenteral nutrition therapy.
7. Select methods for ensuring appropriate glycemic control in critically ill patients.
8. Identify pertinent drug-nutrient interactions, and provide recommendations for the safe and effective delivery of medications to patients receiving enteral or parenteral nutrition therapy.